Proglumide

cholecystokinin ; Homo sapiens







35 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24914377 Investigation of cholecystokinin receptors in the human lower esophageal sphincter. 2014 Jun 7 1
2 25362597 Ameliorating effects of proglumide on neurobehavioral and biochemical deficits in animal model of status epilepticus. 2014 Nov 8
3 16524505 [Receptor mechanisms underlying the modulation of lipopolysaccharide-induced nuclear factor-kappaB expression in vascular endothelial cells by cholecystokinin octapeptide]. 2006 Mar 1
4 17108175 The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. 2006 Nov 15 3
5 12792559 The cholecystokinin antagonist proglumide enhances the analgesic effect of dihydrocodeine. 2003 May-Jun 3
6 11039479 The cholecystokinin antagonist proglumide has an analgesic effect in chronic pancreatitis. 2000 Oct 1
7 9654837 Proglumide as a morphine adjunct in cancer pain management. 1998 May 2
8 9806692 The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain. 1998 Nov 3
9 9211474 Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. 1997 Jun 2
10 8783319 The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. 1996 Mar 3
11 7512698 Brain cholecystokinin octopeptide (CCK-8) concentrations: effect of tryptophan and other serotonergic agents. 1994 Jan 2
12 8052625 Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. 1994 Aug 2 1
13 8317902 Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro. 1993 May-Jun 2
14 1302379 [Effect of CCK receptor antagonists on plasma CCK bioassay]. 1992 Dec 1
15 1327522 Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells. 1992 Nov 1 1
16 2027496 Treatment of Parkinson's disease with proglumide, a CCK antagonist. 1991 May 1
17 2087519 Satiety function of neurons containing a CCK-like substance in the dorsal parabrachial nucleus. 1990 Dec 3
18 2226098 Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. 1990 Nov 1
19 2532974 [Effect of proglumide (PGM) on bile flow and contents in humans and animals]. 1989 Aug 2
20 2694075 The role of CCK caerulein, and CCK antagonists in nociception. 1989 Dec 1
21 3233498 Attenuation of dark-induced hyperlocomotion by a cholecystokinin antagonist in the nucleus accumbens. 1988 Nov 15 1
22 2894431 Proglumide, a cholecystokinin receptor antagonist, exacerbates alloxan-induced diabetes mellitus in Swiss mice. 1987 Dec 1
23 3037032 Cholecystokinin stimulates dopamine synthesis in synaptosomes by a cyclic AMP-dependent mechanism. 1987 Aug 2
24 3432123 The influence of proglumide, a putative CCK antagonist, on cerebral ischemia in gerbil. 1987 Sep-Oct 2
25 3618836 Endogenous and exogenous cholecystokinin may reduce food intake by different mechanisms. 1987 Aug 1
26 3656653 [Cholecystokinin antagonist (proglumide) potentiates the inhibitory effect of morphine on micturition reflex]. 1987 Jun 1
27 3817397 Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi. 1987 Mar 1
28 2419234 Cholecystokinin antagonists. 1986 Jan 2
29 3737785 Does the cholecystokinin antagonist proglumide possess antipsychotic activity? 1986 May 2
30 3801862 In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens. 1986 Nov 5 1
31 3838690 Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide. 1985 Feb 18 1
32 3838691 Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates. 1985 Feb 18 2
33 4014744 Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist. 1985 Aug 2
34 4040554 Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence. 1985 Aug 2
35 6145498 Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. 1984 May 21 2